Market closed

Edgewise Therapeutics/$EWTX

14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX

About Edgewise Therapeutics

Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.

Ticker

$EWTX
Trading on

Industry

Pharmaceuticals

Employees

108

EWTX Metrics

BasicAdvanced
$3.3B
Market cap
-
P/E ratio
-$1.46
EPS
0.15
Beta
-
Dividend rate
$3.3B
0.15
$35.66
$5.34
913K
26.346
25.982
0.705
0.908
-22.36%
-31.90%
6.8
6.8
-27.152
3.69%
0.66%

What the Analysts think about EWTX

Analyst Ratings

Analyst ratings (Buy, Hold, Sell) for Edgewise Therapeutics stock.

EWTX Financial Performance

Income Statement

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EWTX Earnings Performance

Earnings per share (EPS)

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $EWTX

$

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Edgewise Therapeutics stock?

Edgewise Therapeutics (EWTX) has a market cap of $3.3B as of November 14, 2024.

What is the P/E ratio for Edgewise Therapeutics stock?

The price to earnings (P/E) ratio for Edgewise Therapeutics (EWTX) stock is 0 as of November 14, 2024.

Does Edgewise Therapeutics stock pay dividends?

No, Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders as of November 14, 2024.

When is the next Edgewise Therapeutics dividend payment date?

Edgewise Therapeutics (EWTX) stock does not pay dividends to its shareholders.

What is the beta indicator for Edgewise Therapeutics?

Edgewise Therapeutics (EWTX) has a beta rating of 0.15. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.